Loading clinical trials...
Loading clinical trials...
The primary objective of this study is to identify any changes on the safety profile of adverse events and serious adverse events. And the secondary objective is to evaluate clinical response in the c...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Pfizer
NCT06162286 · Community-acquired Bacterial Pneumonia
NCT01168713 · Community-Acquired Bacterial Pneumonia
NCT01756339 · Community-acquired Bacterial Pneumonia
NCT01666743 · Community-Acquired Bacterial Pneumonia (CABP)
NCT01198626 · Community-Acquired Bacterial Pneumonia (CABP)
Ajou University Hospital
Suwon, Gyeonggi-do
Pusan National University Yangsan Hospital
Yangsan, Gyeongsangnam-do
Gachon University Gil Hospital
Namdong-gu, Incheon
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions